The Effect of Dorsal Genital Nerve Stimulation on Opening Urethral Pressure

Inclusion Criteria: * Normal weight (Body weight 50 kg or more, Body Mass Index 18-5-30 kg/m2) * Signed an informed consent Exclusion Criteria: Any history of clinically significant diseases, unless regarded irrelevant and/or stable by the investigator * Any history or evidence of clinically significant urinary incontinence, urinary retention, overactive bladder, or other voiding dysfunction * Known or suspected nerve injuries or paraesthesia in the pelvic area * Pregnancy within six months before enrolment * Breastfeeding within three months before enrolment * Smoking or other regular use of any form of nicotine product during the study period and the previous 3 months * Current or prior participation (within 3 months before screening) in other clinical trials that might affect the results of this study (judged by the investigator) * Any systemic drug use within 2 weeks before the first study day (prescription drugs, over-the-counter drugs, herbal drugs, and/or illicit drugs), except for occasional use of paracetamol (up to 4 g/day), ibuprofen, or antihistamine, hormonal contraceptives and hormone replacement therapy.